At the news
? BEARISHIMPACT 6/10 144 filed Jun 11, 2026 at 16:47 ET
Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 notice of intent to sell 35,000 common shares valued at approximately $1.85 million, to be executed through Morgan Stanley. The filing also reveals a heavy pattern of insider selling: Mulroy has sold over 260,000 shares in the past three weeks (May 15–June 10), totaling about $13.4 million, all via open-market sales after stock option exercises. This sustained selling by a top officer ahead of any public catalyst is a significant bearish signal.
- Officer Dennis Mulroy filed Form 144 to sell 35,000 shares (~$1.85M) on June 11, 2026.
- The filing reveals 18 prior open-market sales between May 15 and June 10, 2026, totaling ~260,000 shares and ~$13.4M.
- All sales were executed after stock option exercises, indicating a systematic plan to monetize equity.
- AnaptysBio has a $1.5B market cap and 94% analyst bullish consensus, making the insider selling pattern particularly notable.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access